Michael Wood | LifeSci Advisors |
Chaim Lebovits | Chief Executive Officer |
Ralph Kern | President and Chief Medical Officer |
Revital Geffen-Aricha | Vice President of Research of and Development |
Preetam Shah | Executive Vice President and Chief Financial Officer |
Jason McCarthy | Maxim Group |
David Bautz | Zacks Small-Cap Research |
Jason Kolbert | Dawson James |
John Evans | Raymond James |
Greetings everyone and welcome to the BrainStorm Cell Therapeutics’ Financial Results for the Second Quarter of 2020 and Corporate Update Conference Call. At this time, all participants are in listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator instructions] As a reminder, today’s conference call is being recorded. It is now my pleasure to introduce your host, Michael Wood of LifeSci Advisors.